The Association of Racing Commissioners International voted July 31 to approve model rules that create a points system and enhanced penalties for drug violations.
- By Tom LaMarra
An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.
The West Virginia Racing Commission July 23 unanimously approved revised Thoroughbred racing rules, including several amendments that deal with equine medication and drug testing.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
- By Tom LaMarra
The Racing Medication and Testing Consortium said July 19 its board of directors has approved a model rule on multiple violation penalties and forwarded the suggested change to racing commissioners for consideration.
- By Tom LaMarra
A horsemen's group official involved in development of the proposed model rule for multiple violation penalties said July 15 the regulations are a "living document" that probably will be adjusted based on industry needs.
The National Horsemen's Benevolent and Protective Association board of directors July 14 signed off on recommended changes to a proposed model rule on medication penalties but acknowledged acceptance could be hard to achieve.
Scientific and regulatory advisers to the National Horsemen's Benevolent and Protective Association July 13 expressed concerns over the proposed withdrawal time and testing level for the bronchodilator clenbuterol.
The National Horsemen's Benevolent and Protective Association most likely will make recommendations for revisions to the proposed national model rule on medication penalties.
Horsemen will pay more to offset the cost of equine drug testing under a resolution adopted by the Ohio State Racing Commission June 27.
- By Tom LaMarra
Racing organizations are moving ahead with plans to implement a points-driven penalty system for equine medication violations.
A U.S. Senator and four members of the House of Representatives have introduced the Horseracing Integrity and Safety Act of 2013 to regulate/prohibit substances, methods, and treatments that may be used in racing.
Federal intervention is the only way horse racing can resolve issues surrounding equine medication use, drug testing, and sufficient investigatory programs, said an attorney, also a Kentucky racing commissioner, May 2.
- By Tom LaMarra
As predicted by horsemen earlier this year, members of Congress are again preparing to introduce legislation that would regulate the use of medication in racehorses.
The British Horseracing Authority, in a recap of a hearing into trainer Mahmood Al Zarooni's admitted use of anabolic steroids in some of his racehorses, called it a "deliberate flouting" of the rules of racing.
A better presentation would be helpful, as would better information. read blog
Among the speakers for an April 9 seminar on exercise-induced pulmonary hemorrhage are three trainers, officials announced.
Horses competing in the April 6 Wood Memorial Stakes (gr. I) at Aqueduct Racetrack and the Santa Anita Derby (gr. I) at Santa Anita park will be monitored beginning April 3 as part of enhanced security measures.
Racing Commissioners International gave final approval April 2 to the "RCI Controlled Therapeutic Medication Schedule," setting the stage for uniform implementation of racing medication rules in the U.S.
- By Tom LaMarra
The horse racing industry is taking a closer look at a relaxant that produces optimum results when administered within a few hours of a race. The prevalence of GABA, a supplement, is open to speculation.
The California Horse Racing Board, citing feed contamination, has dismissed 48 positive tests for zilpaterol, which is used in cattle.
Penn National Gaming Inc. has updated its guide for horsemen to reflect sanctions against those involved with racehorses that test positive for illegal medications.
The regulators of eight states in the Northeast region have committed to a uniform medication and drug testing program in a move supporters believe is a step toward uniform regulation of medication and drug testing.
Regulators from 24 North American racing jurisdictions met via conference call March 4 to discuss new model medication rules set to be adopted by Racing Commissioners International.
Oliver Tait, Darley's chief operating officer, has resigned from the board of the Breeders' Cup following a board decision not to implement a ban on race-day medication for all championship races this year.
The West Virginia Racing Commission Feb. 26 approved a resolution agreeing in principle with the effort to bring uniform medication, penalty, and testing rules to racing jurisdictions in the Mid-Atlantic and Northeast.
The National Horsemen's Benevolent and Protective Association Medication Committee voted Feb. 23 to endorse the use of race-day furosemide, also called Salix or Lasix, at this year's Breeders' Cup World Championships.
Horsemen expect members of Congress to make another attempt at winning support for legislation that would regulate medication use in racehorses by banning all race-day administration.
The Maryland Racing Commission voted Feb. 19 to adopt a uniform equine medication, penalty, and testing program proposed for Thoroughbred and Standardbred racetracks throughout the Mid-Atlantic region.
The California Horse Racing Board will conduct its regular meeting Thursday, Feb. 21, at Santa Anita Park.
A search committee has been formed to find an equine veterinary medical director for the New York Racing Association.
Industry stakeholders, mostly from the Mid-Atlantic and Northeast, met Feb. 6 in Delaware to examine equine medication policy in an attempt to bring about uniformity from state to state.
A group of scientists met with representatives of the Thoroughbred Owners of California Jan. 18 to discuss exercise-induced pulmonary hemorrhaging and later issued a joint statement supporting use of furosemide.
Legislation calling for a ban on performance-enhancing drugs in horse racing has been sent to the New York Senate Racing, Gaming, and Wagering Committee.
New York racing regulators have amended rules, originally set to take effect Dec. 12, affecting the use of Clenbuterol and DempMedrol on Thoroughbred racehorses.
Racing jurisdictions and racetracks are making some headway on tightening the screws on integrity in the sport, though one official Dec. 6 described it as a "minefield" due to legal issues and court fights.
The $25,000 prize intended for three New York Times writers will instead benefit drug testing programs. The newspaper's editorial ethics policy prohibits the writers from accepting the award.
The use of racehorse medications and importance of owner education were among the topics discussed among trainers Kellyn Gorder, Tom Proctor, and Phil Sims at the Welfare and Safety of the Racehorse Summit at Keeneland.
Prodded by a rash of equine deaths at Aqueduct Racetrack last winter, the New York State Racing and Wagering Board Oct. 11 imposed what officials promised will be the first round of rules intended to make for safer racing.
New York racing officials are set to begin implementing new rules based on recommendations by a recent industry task force report to increase safety conditions for horses and jockeys.
Racing consultant Earl Ola talks about the relationship between conditioning and exercise-induced pulmonary hemorrhaging (EIPH), also known as bleeding read blog
A task force has determined the spate of fatal racehorse breakdowns at Aqueduct Racetrack this past winter was primarily the result of structural deficiencies in rules and regulations employed by NYRA and racing regulators.
Nearly two months have passed since a coalition of more than 60 owners launched an experiment into Salix-free racing, pledging to run their 2-year-olds without the controversial anti-bleeder medication read blog
R.D. Hubbard, chairman and majority owner of Ruidoso Downs in New Mexico, announced Sept. 3 that serious drug offenders will be banned from the race track's private property beginning in 2013.
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
Kentucky Gov. Steve Beshear Aug. 30 said regulations designed to reform some aspects of the state's equine medication policy will be implemented despite action by a legislative committee that found them deficient.
Two more national organizations have called on Kentucky to move forward with medication reform regulations shot down by a legislative committee Aug. 27.
Two national organizations said Aug. 28 they find it "troubling" factions in Kentucky horse racing are opposing medication regulations proposed by the Kentucky Horse Racing Commission but shot down by a legislative committee.
The West Virginia Racing Commission has officially scheduled a meeting for Sept. 17 to take comments from industry representatives on the use of furosemide, also known as Salix or Lasix, on race day.
A Kentucky legislative subcommittee, in a surprise vote, found regulations governing equine medication "deficient" Aug. 27, just one week before they are scheduled to take effect.
Most Popular Stories
- Scholarship Named in Honor of Thornbury
- Baffert Quartet Faces Shared Belief in Malibu
- Champion High Chaparral Euthanized at 15
- Gulfstream Builds Stalls for Displaced Horses
- Awesome Baby Heads Speedy Field in La Brea
- Dortmund Wins Dramatic Los Alamitos Futurity
- Los Alamitos Concludes Successful Winter Meet
- Clement Trio Looms Large in La Prevoyante
- Strong Field Set for Mathis Brothers Mile
- Divine Oath, North Slope Meet in McKnight